Monitoring asthma in children

European Respiratory Journal

Volumn 45, Issue 4, 2015, Pages 906-925

  Pijnenburg, Mariëlle W ^a   Baraldi, Eugenio ^b   Brand, Paul L P ^c,d   Carlsen, Kai Håkon ^e   Eber, Ernst ^f   Frischer, Thomas ^g   Hedlin, Gunilla ^h   Kulkarni, Neeta ⁱ   Lex, Christiane ^j   Mäkelä, Mika J ^k   Mantzouranis, Eva ^l   Moeller, Alexander ^m   Pavord, Ian ⁿ   Piacentini, Giorgio ^o   Price, David ^p   Rottier, Bart L ^d   Saglani, Sejal ^q   Sly, Peter D ^r   Szefler, Stanley J ^s   Tonia, Thomy ^t   Turner, Steve ^p   Wooler, Edwina ^u   Lødrup Carlsen, Karin C ^e,v   more..

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b UNIVERSITY OF PADOVA   (Italy)

^c ISALA HOSPITAL   (Netherlands)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^e OSLO UNIVERSITY HOSPITAL   (Norway)

^f MEDICAL UNIVERSITY OF GRAZ   (Austria)

^g WILHELMINEN HOSPITAL   (Austria)

^h KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

ⁱ UNIVERSITY OF LEICESTER   (United Kingdom)

^j UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^k HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^l UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^m UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

ⁿ UNIVERSITY OF OXFORD   (United Kingdom)

^o UNIVERSITY OF VERONA   (Italy)

^p UNIVERSITY OF ABERDEEN   (United Kingdom)

^q NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^r UNIVERSITY OF QUEENSLAND   (Australia)

^s UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^t UNIVERSITY OF BERN   (Switzerland)

^u ROYAL ALEXANDRA CHILDREN S HOSPITAL   (United Kingdom)

^v UNIVERSITY OF OSLO   (Norway)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; BECLOMETASONE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BIOLOGICAL MARKER; LEUKOTRIENE RECEPTOR BLOCKING AGENT; TOBACCO SMOKE; ANTIASTHMATIC AGENT;

AGE; AIR POLLUTION; ARTICLE; ASTHMA; BODY PLETHYSMOGRAPHY; BREATH ANALYSIS; BRONCHIAL RESPONSIVENESS; COMORBIDITY; CONSENSUS; DELPHI STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; ENVIRONMENTAL FACTOR; FOOD ALLERGY; HOARSENESS; HUMAN; LUNG FUNCTION; PATIENT MONITORING; PEAK EXPIRATORY FLOW; PHENOTYPE; PRIORITY JOURNAL; QUALITY OF LIFE; RESPIRATORY TRACT PARAMETERS; RHINITIS; SPIROMETRY; SPUTUM ANALYSIS; SYSTEMATIC REVIEW; TELEMONITORING; THRUSH; ADVISORY COMMITTEE; BRONCHIAL HYPERREACTIVITY; DISEASE COURSE; FEMALE; INFANT; MALE; PHYSIOLOGIC MONITORING; PRACTICE GUIDELINE; PRESCHOOL CHILD; PROCEDURES; PROGNOSIS; QUESTIONNAIRE; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STANDARDS; UNITED STATES;

ADVISORY COMMITTEES; AGE FACTORS; ANTI-ASTHMATIC AGENTS; ASTHMA; BRONCHIAL HYPERREACTIVITY; CHILD, PRESCHOOL; DISEASE PROGRESSION; FEMALE; HUMANS; INFANT; MALE; MONITORING, PHYSIOLOGIC; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SPIROMETRY; SURVEYS AND QUESTIONNAIRES; UNITED STATES;

EID: 84926464918     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00088814     Document Type: Article

References (223)

1. National Asthma Education and Prevention Program. Expert panel report 3 (EPR-3): guidelines for the diagnosis and management of asthma - summary report 2007. J Allergy Clin Immunol 2007; 120: Suppl. 5, S94-S138.
2. Saglani S, Payne DN, Zhu J, et al. Early detection of airway wall remodeling and eosinophilic inflammation in preschool wheezers. Am J Respir Crit Care Med 2007; 176: 858-864.
3. Saglani S, Malmstrom K, Pelkonen AS, et al. Airway remodeling and inflammation in symptomatic infants with reversible airflow obstruction. Am J Respir Crit Care Med 2005; 171: 722-727.
4. Reddel HK, Taylor DR, Bateman ED, et al. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med 2009; 180: 59-99.
5. Bacharier LB, Boner A, Carlsen KH, et al. Diagnosis and treatment of asthma in childhood: a PRACTALL consensus report. Allergy 2008; 63: 5-34.
6. British Thoracic Society Scottish Intercollegiate Guidelines. British guideline on the management of asthma. Thorax 2008; 63: Suppl. 4, iv1-iv121.
7. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention, revised 2014. Available from www.ginasthma.org
8. Fuhlbrigge AL, Guilbert T, Spahn J, et al. The influence of variation in type and pattern of symptoms on assessment in pediatric asthma. Pediatrics 2006; 118: 619-625.
9. Gustafsson PM, Watson L, Davis KJ, et al. Poor asthma control in children: evidence from epidemiological surveys and implications for clinical practice. Int J Clin Pract 2006; 60: 321-334.
10. Chipps BE, Zeiger RS, Borish L, et al. Key findings and clinical implications from the epidemiology and natural history of asthma: outcomes and treatment tegimens (TENOR) study. J Allergy Clin Immunol 2012; 130: 332-342.
11. Moeller A, Carlsen K-H, Sly PD, et al. Monitoring of asthma in children: lung function, bronchial responsiveness and inflammation. Eur Respir Rev 2015; [In press DOI: 10.1183/16000617.00003914].
12. Brand PLP, Mäkelä M, Szefler SJ, et al. Monitoring of asthma in children: symptoms, exacerbations and quality of life. Eur Respir Rev 2015; [In press DOI: 10.1183/16000617.00003614].
13. Lødrup Carlsen KC, Pijnenburg MW. Monitoring of asthma in children. Eur Respir Rev 2015; [In press DOI: 10.1183/16000617.00003714].
14. Rottier BL, Eber E, Hedlin G, et al. Monitoring of asthma in children: management-related issues. Eur Respir Rev 2015; [In press DOI: 10.1183/16000617.00003814].
15. Koh MS, Irving LB. The natural history of asthma from childhood to adulthood. Int J Clin Pract 2007; 61: 1371-1374.
16. Holt EW, Cook EF, Covar RA, et al. Identifying the components of asthma health status in children with mild to moderate asthma. J Allergy Clin Immunol 2008; 121: 1175-1180.
17. de Jongste JC, Carraro S, Hop WC, et al. Daily telemonitoring of exhaled nitric oxide and symptoms in the treatment of childhood asthma. Am J Respir Crit Care Med 2009; 179: 93-97.
18. Deschildre A, Beghin L, Salleron J, et al. Home telemonitoring (forced expiratory volume in 1 s) in children with severe asthma does not reduce exacerbations. Eur Respir J 2012; 39: 290-296.
19. Wensley D, Silverman M. Peak flow monitoring for guided self-management in childhood asthma - a randomized controlled trial. Am J Respir Crit Care Med 2004; 170: 606-612.
20. Klok T, de Groot EP, Brouwer AFJ, et al. Follow-up of children with asthma. In: Carlsen K-H, Gerritsen J, eds. Paediatric Asthma. ERS Monogr 2012; 56: 210-223.
21. Rikkers-Mutsaerts ERVM, Winters AE, Bakker MJ, et al. Internet-based self-management compared with usual care in adolescents with asthma: a randomized controlled trial. Pediatr Pulm 2012; 47: 1170-1179.
22. Hedlin G, Bush A, Carlsen KL, et al. Problematic severe asthma in children, not one problem but many: a GA(2) LEN initiative. Eur Respir J 2010; 36: 196-201.
23. Lang A, Carlsen KH, Haaland G, et al. Severe asthma in childhood: assessed in 10 year olds in a birth cohort study. Allergy 2008; 63: 1054-1060.
24. Lodrup Carlsen KC, Hedlin G, Bush A, et al. Assessment of problematic severe asthma in children. Eur Respir J 2011; 37: 432-440.
25. Fleming L, Wilson N, Regamey N, et al. Use of sputum eosinophil counts to guide management in children with severe asthma. Thorax 2012; 67: 193-198.
26. Spycher BD, Silverman M, Kuehni CE. Phenotypes of childhood asthma: are they real? Clin Exp Allergy 2010; 40: 1130-1141.
27. Bousquet J, Anto J, Auffray C, et al. MeDALL (Mechanisms of the Development of ALLergy): an integrated approach from phenotypes to systems medicine. Allergy 2011; 66: 596-604.
28. Lotvall J, Akdis CA, Bacharier LB, et al. Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome. J Allergy Clin Immunol 2011; 127: 355-360.
29. Saglani S, Bush A. Asthma, atopy, and airway inflammation: what does it mean in practice? Am J Respir Crit Care Med 2008; 178: 437-438.
30. Saglani S, Bush A. The early-life origins of asthma. Curr Opin Allergy Clin Immunol 2007; 7: 83-90.
31. Szefler SJ, Martin RJ, King TS, et al. Significant variability in response to inhaled corticosteroids for persistent asthma. J Allergy Clin Immunol 2002; 109: 410-418.
32. Szefler SJ, Phillips BR, Martinez FD, et al. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma. J Allergy Clin Immunol 2005; 115: 233-242.
33. Brasier AR, Victor S, Ju H, et al. Predicting intermediate phenotypes in asthma using bronchoalveolar lavage-derived cytokines. Clin Transl Sci 2010; 3: 147-157.
34. Etzel RA. How environmental exposures influence the development and exacerbation of asthma. Pediatrics 2003; 112: 233-239.
35. Forno E, Fuhlbrigge A, Soto-Quiros ME, et al. Risk factors and predictive clinical scores for asthma exacerbations in childhood. Chest 2010; 138: 1156-1165.
36. Fuhlbrigge AL, Kitch BT, Paltiel AD, et al. FEV(1) is associated with risk of asthma attacks in a pediatric population. J Allergy Clin Immunol 2001; 107: 61-67.
37. Lee YJ, Kim KW, Choi BS, et al. Clinical characteristics of eosinophilic and noneosinophilic asthma in children. Acta Paediatrica 2013; 102: 53-57.
38. McCarville M, Sohn MW, Oh E, et al. Environmental tobacco smoke and asthma exacerbations and severity: the difference between measured and reported exposure. Arch Dis in Child 2013; 98: 510-514.
39. McConnochie KM, Russo MJ, McBride JT, et al. Socioeconomic variation in asthma hospitalization: excess utilization or greater need? Pediatrics 1999; 103: e75.
40. Schatz M, Zeiger RS, Yang SJ, et al. The relationship of asthma impairment determined by psychometric tools to future asthma exacerbations. Chest 2012; 141: 66-72.
41. de Groot EP, Nijkamp A, Duiverman EJ, et al. Allergic rhinitis is associated with poor asthma control in children with asthma. Thorax 2012; 67: 582-587.
42. Thomas M, Kocevar VS, Zhang QY, et al. Asthma-related health care resource use among asthmatic children with and without concomitant allergic rhinitis. Pediatrics 2005; 115: 129-134.
43. Bracken M, Fleming L, Hall P, et al. The importance of nurse-led home visits in the assessment of children with problematic asthma. Arch Dis Child 2009; 94: 780-784.
44. Kalliola S, Pelkonen AS, Malmberg LP, et al. Maternal smoking affects lung function and airway inflammation in young children with multiple-trigger wheeze. J Allergy Clin Immun 2013; 131: 730-735.
45. Azizi BH, Henry RL. The effects of indoor environmental factors on respiratory illness in primary school children in Kuala Lumpur. Int J Epidemiol 1991; 20: 144-150.
46. Fagbule D, Ekanem EE. Some environmental risk factors for childhood asthma: a case-control study. Ann Trop Paediatr 1994; 14: 15-19.
47. Health Effects Institute. Traffic-Related Air Pollution: a Critical Review of the Literature on Emissions, Exposure, and Health Effects. Boston, Health Effects Institute, 2010.
48. Kilpelainen M, Terho EO, Helenius H, et al. Home dampness, current allergic diseases, and respiratory infections among young adults. Thorax 2001; 56: 462-467.
49. Koo LC, Ho JH-C. Mosquito coil smoke and respiratory health among Hong Kong Chinese: results of three epidemiological studies. Indoor and Built Environment 1994; 3: 304-310.
50. Lin TC, Krishnaswamy G, Chi DS. Incense smoke: clinical, structural and molecular effects on airway disease. Clin Mol Allergy 2008; 6: 3.
51. Liu W, Zhang J, Hashim JH, et al. Mosquito coil emissions and health implications. Environ Health Perspect 2003; 111: 1454-1460.
52. Nastos PT, Paliatsos AG, Anthracopoulos MB, et al. Outdoor particulate matter and childhood asthma admissions in Athens, Greece: a time-series study. Environ Health 2010; 9: 45.
53. Quansah R, Jaakkola MS, Hugg TT, et al. Residential dampness and molds and the risk of developing asthma: a systematic review and meta-analysis. PLoS One 2012; 7: e47526.
54. Spira-Cohen A, Chen LC, Kendall M, et al. Personal exposures to traffic-related air pollution and acute respiratory health among Bronx schoolchildren with asthma. Environ Health Perspect 2011; 119: 559-565.
55. Torres-Duque C, Maldonado D, Perez-Padilla R, et al. Biomass fuels and respiratory diseases: a review of the evidence. Proc Am Thorac Soc 2008; 5: 577-590.
56. Wang IJ, Tsai CH, Chen CH, et al. Glutathione S-transferase, incense burning and asthma in children. Eur Respir J 2011; 37: 1371-1377.
57. Haahtela T, Tuomisto LE, Pietinalho A, et al. A 10 year asthma programme in Finland: major change for the better. Thorax 2006; 61: 663-670.
58. Kupczyk M, Haahtela T, Cruz AA, et al. Reduction of asthma burden is possible through National Asthma Plans. Allergy 2010; 65: 415-419.
59. Kauppi P, Linna M, Martikainen J, et al. Follow-up of the Finnish Asthma Programme 2000-2010: reduction of hospital burden needs risk group rethinking. Thorax 2013; 68: 292-293.
60. Brouwer AF, Brand PL, Roorda RJ, et al. Airway obstruction at time of symptoms prompting use of reliever therapy in children with asthma. Acta Paediatrica 2010; 99: 871-876.
61. Wildhaber J, Carroll WD, Brand PL. Global impact of asthma on children and adolescents' daily lives: the room to breathe survey. Pediatr Pulmonol 2012; 47: 346-357.
62. Arga M, Sahbaz H, Bakirtas A, et al. Does self-monitoring by means of symptom diaries improve asthma control in children? J Asthma 2014; 51: 299-305.
63. Cloutier MM, Schatz M, Castro M, et al. Asthma outcomes: composite scores of asthma control. J Allergy Clin Immunol 2012; 129: Suppl. 3, S24-S33.
64. Liu AH, Zeiger R, Sorkness C, et al. Development and cross-sectional validation of the Childhood Asthma Control Test. J Allergy Clin Immunol 2007; 119: 817-825.
65. Juniper EF, Gruffydd-Jones K, Ward S, et al. Asthma control questionnaire in children: validation, measurement properties, interpretation. Eur Respir J 2010; 36: 1410-1416.
66. Bousquet J, Mantzouranis E, Cruz AA, et al. Uniform definition of asthma severity, control, and exacerbations: Document presented for the World Health Organization Consultation on Severe Asthma. J Allergy Clin Immunol 2010; 126: 926-938.
67. Bateman ED, Reddel HK, Eriksson G, et al. Overall asthma control: the relationship between current control and future risk. J Allergy Clin Immunol 2010; 125: 600-608.
68. Wu AC, Tantisira K, Li LL, et al. Predictors of symptoms are different from predictors of severe exacerbations from asthma in children. Chest 2011; 140: 100-107.
69. Koster ES, Raaijmakers JAM, Vijverberg SJH, et al. Limited agreement between current and long-term asthma control in children: the PACMAN cohort study. Pediat Allerg Imm-Uk 2011; 22: 776-783.
70. Koolen BB, Pijnenburg MW, Brackel HJ, et al. Comparing global initiative for asthma (GINA) criteria with the childhood asthma control test (C-ACT) and asthma control test (ACT). Eur Respir J 2011; 38: 561-566.
71. Murphy KR, Zeiger RS, Kosinski M, et al. Test for Respiratory and Asthma Control in Kids (TRACK): a caregiver-completed questionnaire for preschool-aged children. J Allergy Clin Immunol 2009; 123: 833-839.
72. Wildfire JJ, Gergen PJ, Sorkness CA, et al. Development and validation of the Composite Asthma Severity Index - an outcome measure for use in children and adolescents. J Allergy Clin Immunol 2012; 129: 694-701.
73. de Blic J, Boucot I, Pribil C, et al. Control of asthma in children: still unacceptable? A French cross-sectional study. Respir Med 2009; 103: 1383-1391.
74. Piacentini GL, Peroni DG, Bodini A, et al. Childhood asthma control test and airway inflammation evaluation in asthmatic children. Allergy 2009; 64: 1753-1757.
75. Stanford RH, Gilsenan AW, Ziemiecki R, et al. Predictors of uncontrolled asthma in adult and pediatric patients: analysis of the asthma control characteristics and prevalence survey studies (ACCESS). J Asthma 2010; 47: 257-262.
76. Ito Y, Adachi Y, Itazawa T, et al. Association between the results of the childhood asthma control test and objective parameters in asthmatic children. J Asthma 2011; 48: 1076-1080.
77. van Dalen C, Harding E, Parkin J, et al. Suitability of forced expiratory volume in 1 second/forced vital capacity vs percentage of predicted forced expiratory volume in 1 second for the classification of asthma severity in adolescents. Arch Pediat Adol Med 2008; 162: 1169-1174.
78. Chipps B, Zeiger RS, Murphy K, et al. Longitudinal validation of the test for respiratory and asthma control in kids in pediatric practices. Pediatrics 2011; 127: E737-E747.
79. Voorend-van Bergen S, Brackel H, Caudri D, et al. Assessment of asthma control by children and parents. Eur Respir J 2013; 41: 233-234.
80. McLean S, Chandler D, Nurmatov U, et al. Telehealthcare for asthma: a Cochrane review. Can Med Assoc J 2011; 183: E733-E742.
81. Carroll WD, Wildhaber J, Brand PLP. Parent misperception of control in childhood/adolescent asthma: the Room to Breathe survey. Eur Respir J 2012; 39: 90-96.
82. Fuhrman C, Dubus JC, Marguet C, et al. Hospitalizations for asthma in children are linked to undertreatment and insufficient asthma education. J Asthma 2011; 48: 565-571.
83. Ungar WJ, Paterson JM, Gomes T, et al. Relationship of asthma management, socioeconomic status, and medication insurance characteristics to exacerbation frequency in children with asthma. Ann Allergy Asthma Immunol 2011; 106: 17-23.
84. Visser CA, Brand PL. Does a single measurement of exhaled nitric oxide predict asthma exacerbations? Arch Dis Child 2011; 96: 781-782.
85. Williams LK, Peterson EL, Wells K, et al. Quantifying the proportion of severe asthma exacerbations attributable to inhaled corticosteroid nonadherence. J Allergy Clin Immunol 2011; 128: 1185-1191.
86. Gillman A, Douglass JA. What do asthmatics have to fear from food and additive allergy? Clin Exp Allergy 2010; 40: 1295-1302.
87. Wilson SR, Rand CS, Cabana MD, et al. Asthma outcomes: quality of life. J Allergy Clin Immunol 2012; 129: Suppl. 3, S88-S123.
88. Oswald H, Phelan PD, Lanigan A, et al. Childhood asthma and lung function in mid-adult life. Pediatr Pulmonol 1997; 23: 14-20.
89. Sears MR, Greene JM, Willan AR, et al. A longitudinal, population-based, cohort study of childhood asthma followed to adulthood. N Engl J Med 2003; 349: 1414-1422.
90. Tosca MA, Silvestri M, Olcese R, et al. Breathlessness perception assessed by visual analogue scale and lung function in children with asthma: a real-life study. Pediatr Allergy Immunol 2012; 23: 537-542.
91. Baker RR, Mishoe SC, Zaitoun FH, et al. Poor perception of airway obstruction in children with asthma. J Asthma 2000; 37: 613-624.
92. Liu AH. Biomarkers and childhood asthma: improving control today and tomorrow. Allergy Asthma Proc 2005; 26: 249-254.
93. Galant SP, Morphew T, Newcomb RL, et al. The relationship of the bronchodilator response phenotype to poor asthma control in children with normal spirometry. J Pediatr 2011; 158: 953-959.
94. Tantisira KG, Fuhlbrigge AL, Tonascia J, et al. Bronchodilation and bronchoconstriction: predictors of future lung function in childhood asthma. J Allergy Clin Immunol 2006; 117: 1264-1271.
95. National Asthma Education and Prevention Program. National asthma education and prevention program. Expert panel report: guidelines for the diagnosis and management of asthma update on selected topics - 2002. J Allergy Clin Immunol 2002; 110: Suppl. 5, S141-S219.
96. Jones MH, Howard J, Davis S, et al. Sensitivity of spirometric measurements to detect airway obstruction in infants. Am J Respir Crit Care Med 2003; 167: 1283-1286.
97. Vonk JM, Postma DS, Boezen HM, et al. Childhood factors associated with asthma remission after 30 year follow up. Thorax 2004; 59: 925-929.
98. Brouwer AF, Roorda RJ, Brand PL. Home spirometry and asthma severity in children. Eur Respir J 2006; 28: 1131-1137.
99. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005; 26: 319-338.
100. Kamps AW, Roorda RJ, Brand PL. Peak flow diaries in childhood asthma are unreliable. Thorax 2001; 56: 180-182.
101. Harver A, Humphries CT, Kotses H. Do asthma patients prefer to monitor symptoms or peak flow? J Asthma 2009; 46: 940-943.
102. Mochizuki H, Hirai K, Tabata H. Forced oscillation technique and childhood asthma. Allergol Int 2012; 61: 373-383.
103. Goldman MD. Clinical application of forced oscillation. Pulm Pharmacol Ther 2001; 14: 341-350.
104. Klug B, Bisgaard H. Measurement of lung function in awake 2 -4-year-old asthmatic children during methacholine challenge and acute asthma: a comparison of the impulse oscillation technique, the interrupter technique, and transcutaneous measurement of oxygen versus whole-body plethysmography. Pediatr Pulmonol 1996; 21: 290-300.
105. McKenzie SA, Bridge PD, Pao CS. Lung function tests for pre-school children. Paediatr Respir Rev 2001; 2: 37-45.
106. Hellinckx J, De Boeck K, Bande-Knops J, et al. Bronchodilator response in 3-6.5 years old healthy and stable asthmatic children. Eur Respir J 1998; 12: 438-443.
107. Malmberg LP, Makela MJ, Mattila PS, et al. Exercise-induced changes in respiratory impedance in young wheezy children and nonatopic controls. Pediatr Pulm 2008; 43: 538-544.
108. Nielsen KG, Bisgaard H. Discriminative capacity of bronchodilator response measured with three different lung function techniques in asthmatic and healthy children aged 2 to 5 years. Am J Respir Crit Care Med 2001; 164: 554-559.
109. Oostveen E, Dom S, Desager K, et al. Lung function and bronchodilator response in 4-year-old children with different wheezing phenotypes. Eur Respir J 2010; 35: 865-872.
110. Thamrin C, Gangell CL, Udomittipong K, et al. Assessment of bronchodilator responsiveness in preschool children using forced oscillations. Thorax 2007; 62: 814-819.
111. Jenkins HA, Cherniack R, Szefler SJ, et al. A comparison of the clinical characteristics of children and adults with severe asthma. Chest 2003; 124: 1318-1324.
112. Mahut B, Beydon N, Delclaux C. Overweight is not a comorbidity factor during childhood asthma: the GrowthOb study. Eur Respir J 2012; 39: 1120-1126.
113. Macleod KA, Horsley AR, Bell NJ, et al. Ventilation heterogeneity in children with well controlled asthma with normal spirometry indicates residual airways disease. Thorax 2009; 64: 33-37.
114. Stocks J, Godfrey S, Beardsmore C, et al. Plethysmographic measurements of lung volume and airway resistance. ERS/ATS task force on standards for infant respiratory function testing. European Respiratory Society/American Thoracic Society. Eur Respir J 2001; 17: 302-312.
115. Young S, Arnott J, O'Keeffe PT, et al. The association between early life lung function and wheezing during the first 2 yrs of life. Eur Respir J 2000; 15: 151-157.
116. Haland G, Carlsen KC, Sandvik L, et al. Reduced lung function at birth and the risk of asthma at 10 years of age. N Engl J Med 2006; 355: 1682-1689.
117. Martinez FD, Wright AL, Taussig LM, et al. Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N Engl J Med 1995; 332: 133-138.
118. Turner SW, Palmer LJ, Rye PJ, et al. Infants with flow limitation at 4 weeks: outcome at 6 and 11 years. Am J Respir Crit Care Med 2002; 165: 1294-1298.
119. Turner SW, Young S, Goldblatt J, et al. Childhood asthma and increased airway responsiveness: a relationship that begins in infancy. Am J Respir Crit Care Med 2009; 179: 98-104.
120. Moeller A, Franklin P, Hall GL, et al. Inhaled fluticasone dipropionate decreases levels of nitric oxide in recurrenty wheezy infants. Pediatr Pulmonol 2004; 38: 250-255.
121. Straub DA, Moeller A, Minocchieri S, et al. The effect of montelukast on lung function and exhaled nitric oxide in infants with early childhood asthma. Eur Respir J 2005; 25: 289-294.
122. Pelkonen AS, Kotaniemi-Syrjanen A, Malmstrom K, et al. Clinical findings associated with abnormal lung function in children aged 3-26 months with recurrent respiratory symptoms. Acta Paediatr 2010; 99: 1175-1179.
123. Mallol J, Aguirre V, Barrueto L, et al. Effect of inhaled fluticasone on lung function in infants with recurrent wheezing: a randomised controlled trial. Allergol Immunopathol (Madr) 2009; 37: 57-62.
124. Pelkonen AS, Malmstrom K, Malmberg LP, et al. Budesonide improves decreased airway conductance in infants with respiratory symptoms. Arch Dis Child 2009; 94: 536-541.
125. Pelkonen AS, Malmstrom K, Sarna S, et al. The effect of montelukast on respiratory symptoms and lung function in wheezy infants. Eur Respir J 2013; 41: 664-670.
126. Palmer LJ, Rye PJ, Gibson NA, et al. Airway responsiveness in early infancy predicts asthma, lung function, and respiratory symptoms by school age. Am J Respir Crit Care Med 2001; 163: 37-42.
127. Malmstrom K, Pelkonen AS, Malmberg LP, et al. Lung function, airway remodelling and inflammation in symptomatic infants: outcome at 3 years. Thorax 2011; 66: 157-162.
128. Martinez FD, Morgan WJ, Wright AL, et al. Initial airway function is a risk factor for recurrent wheezing respiratory illnesses during the first three years of life. Group Health Medical Associates. Am Rev Respir Dis 1991; 143: 312-316.
129. Martinez FD, Morgan WJ, Wright AL, et al. Diminished lung function as a predisposing factor for wheezing respiratory illness in infants. N Engl J Med 1988; 319: 1112-1117.
130. Murray CS, Pipis SD, McArdle EC, et al. Lung function at one month of age as a risk factor for infant respiratory symptoms in a high risk population. Thorax 2002; 57: 388-392.
131. Pike KC, Rose-Zerilli MJ, Osvald EC, et al. The relationship between infant lung function and the risk of wheeze in the preschool years. Pediatr Pulmonol 2011; 46: 75-82.
132. Cockcroft DW, Killian DN, Mellon JJ, et al. Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy 1977; 7: 235-243.
133. Hargreave FE, Ryan G, Thomson NC, et al. Bronchial responsiveness to histamine or methacholine in asthma: measurement and clinical significance. J Allergy Clin Immunol 1981; 68: 347-355.
134. Aas K. Bronchial provocation tests in asthma. Arch Dis Child 1970; 45: 221-228.
135. Jones RS, Wharton MJ, Buston MH. The place of physical exercise and bronchodilator drugs in the assessment of the asthmatic child. Arch Dis Child 1963; 38: 539-545.
136. Zach MS, Polgar G. Cold air challenge of airway hyperreactivity in children: dose-response interrelation with a reaction plateau. J Allergy Clin Immunol 1987; 80: 9-17.
137. Rosenthal RR. Simplified eucapnic voluntary hyperventilation challenge. J Allergy Clin Immunol 1984; 73: 676-679.
138. Henriksen JM, Dahl R. Effects of inhaled budesonide alone and in combination with low-dose terbutaline in children with exercise-induced asthma. Am Rev Respir Dis 1983; 128: 993-997.
139. van Essen-Zandvliet EE, Hughes MD, Waalkens HJ, et al. Effects of 22 months of treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. The Dutch Chronic Non-specific Lung Disease Study Group. Am Rev Respir Dis 1992; 146: 547-554.
140. Nuijsink M, Hop WC, Sterk PJ, et al. Long-term asthma treatment guided by airway hyperresponsiveness in children: a randomised controlled trial. Eur Respir J 2007; 30: 457-466.
141. Riiser A, Hovland V, Carlsen KH, et al. Does bronchial hyperresponsiveness in childhood predict active asthma in adolescence? Am J Respir Crit Care Med 2012; 186: 493-500.
142. Piacentini GL, Bodini A, Costella S, et al. Exhaled nitric oxide and sputum eosinophil markers of inflammation in asthmatic children. Eur Respir J 1999; 13: 1386-1390.
143. Lex C, Ferreira F, Zacharasiewicz A, et al. Airway eosinophilia in children with severe asthma - predictive values of noninvasive tests. Am J Respir Crit Care Med 2006; 174: 1286-1291.
144. Taylor DR, Pijnenburg MW, Smith AD, et al. Exhaled nitric oxide measurements: clinical application and interpretation. Thorax 2006; 61: 817-827.
145. Kaptein AA, Hughes BM, Scharloo M, et al. Illness perceptions about asthma are determinants of outcome. J Asthma 2008; 45: 459-464.
146. Dweik RA, Boggs PB, Erzurum SC, et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med 2011; 184: 602-615.
147. Smith AD, Cowan JO, Brassett KP, et al. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med 2005; 352: 2163-2173.
148. Pijnenburg MW, Bakker EM, Hop WC, et al. Titrating steroids on exhaled nitric oxide in children with asthma: a randomized controlled trial. Am J Respir Crit Care Med 2005; 172: 831-836.
149. Fritsch M, Uxa S, Horak F, et al. Exhaled nitric oxide in the management of childhood asthma: a prospective 6-months study. Pediatr Pulmonol 2006; 41: 855-862.
150. Szefler SJ, Mitchell H, Sorkness CA, et al. Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial. Lancet 2008; 372: 1065-1072.
151. Singer F, Luchsinger I, Inci D, et al. Exhaled nitric oxide in symptomatic children at preschool age predicts later asthma. Allergy 2013; 68: 531-538.
152. Moeller A, Diefenbacher C, Lehmann A, et al. Exhaled nitric oxide distinguishes between subgroups of preschool children with respiratory symptoms. J Allergy Clin Immunol 2008; 121: 705-709.
153. Debley JS, Stamey DC, Cochrane ES, et al. Exhaled nitric oxide, lung function, and exacerbations in wheezy infants and toddlers. J Allergy Clin Immunol 2010; 125: 1228-1234.
154. Chawes BL, Buchvald F, Bischoff AL, et al. Elevated exhaled nitric oxide in high-risk neonates precedes transient early but not persistent wheeze. Am J Respir Crit Care Med 2010; 182: 138-142.
155. Petsky HL, Cates CJ, Li A, et al. Tailored interventions based on exhaled nitric oxide versus clinical symptoms for asthma in children and adults. Cochrane Database Syst Rev 2009; 4: CD006340.
156. Efthimiadis A, Jayaram L, Weston S, et al. Induced sputum: time from expectoration to processing. Eur Respir J 2002; 19: 706-708.
157. Lex C, Payne DN, Zacharasiewicz A, et al. Sputum induction in children with difficult asthma: safety, feasibility, and inflammatory cell pattern. Pediatr Pulmonol 2005; 39: 318-324.
158. Gibson PG. Sputum induction in children. Eur Respir J 2002; 20: Suppl. 37, 44s-46s.
159. Zacharasiewicz A, Wilson N, Lex C, et al. Clinical use of noninvasive measurements of airway inflammation in steroid reduction in children. Am J Respir Crit Care Med 2005; 171: 1077-1082.
160. Li AM, Tsang TW, Lam HS, et al. Predictors for failed dose reduction of inhaled corticosteroids in childhood asthma. Respirology 2008; 13: 400-407.
161. Fleming L, Tsartsali L, Wilson N, et al. Sputum inflammatory phenotypes are not stable in children with asthma. Thorax 2012; 67: 675-681.
162. Baraldi E, Ghiro L, Piovan V, et al. Safety and success of exhaled breath condensate collection in asthma. Arch Dis Child 2003; 88: 358-360.
163. Horvath I, Hunt J, Barnes PJ, et al. Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J 2005; 26: 523-548.
164. Klok T, Brand PL, Bomhof-Roordink H, et al. Parental illness perceptions and medication perceptions in childhood asthma, a focus group study. Acta Paediatr 2011; 100: 248-252.
165. Koster ES, Wijga AH, Koppelman GH, et al. Uncontrolled asthma at age 8: the importance of parental perception towards medication. Pediatr Allergy Immunol 2011; 22: 462-468.
166. Kaptein AA, Klok T, Moss-Morris R, et al. Illness perceptions: impact on self-management and control in asthma. Curr Opin Allergy Clin Immunol 2010; 10: 194-199.
167. Brouwer AF, Brand PL. Asthma education and monitoring: what has been shown to work. Paediatr Respir Rev 2008; 9: 193-199.
168. Kuethe MC, Vaessen-Verberne AA, Bindels PJ, et al. Children with asthma on inhaled corticosteroids managed in general practice or by hospital paediatricians: is there a difference? Prim Care Respir J 2010; 19: 62-67.
169. Jentzsch NS, Camargos P, Sarinho ES, et al. Adherence rate to beclomethasone dipropionate and the level of asthma control. Respir Med 2012; 106: 338-343.
170. Nikander K, Turpeinen M, Pelkonen AS, et al. True adherence with the Turbuhaler in young children with asthma. Arch Dis Child 2011; 96: 168-173.
171. Klok T, Kaptein AA, Duiverman EJ, et al. High inhaled corticosteroids adherence in childhood asthma: the role of medication beliefs. Eur Respir J 2012; 40: 1149-1155.
172. Lasmar L, Camargos P, Bousquet J, et al. Factors related to lower adherence rates to inhaled corticosteroids in children and adolescents: a prospective randomized cohort study. J Trop Pediatr 2009; 55: 20-25.
173. Spicher M, Bollers N, Chinn T, et al. Adherence in single-parent households in a long-term asthma clinical trial. Pediatr Nurs 2012; 38: 207-213.
174. Otsuki M, Eakin MN, Rand CS, et al. Adherence feedback to improve asthma outcomes among inner-city children: a randomized trial. Pediatrics 2009; 124: 1513-1521.
175. Bender BG, Bartlett SJ, Rand CS, et al. Impact of interview mode on accuracy of child and parent report of adherence with asthma-controller medication. Pediatrics 2007; 120: e471-e477.
176. Brand PL, Klok T, Kaptein AA. Using communication skills to improve adherence in children with chronic disease: the adherence equation. Paediatr Respir Rev 2013; 14: 219-223.
177. Kamps AW, van Ewijk B, Roorda RJ, et al. Poor inhalation technique, even after inhalation instructions, in children with asthma. Pediatr Pulmonol 2000; 29: 39-42.
178. Kamps AW, Brand PL, Roorda RJ. Determinants of correct inhalation technique in children attending a hospital-based asthma clinic. Acta Paediatr 2002; 91: 159-163.
179. Minai BA, Martin JE, Cohn RC. Results of a physician and respiratory therapist collaborative effort to improve long-term metered-dose inhaler technique in a pediatric asthma clinic. Respir Care 2004; 49: 600-605.
180. Laube BL, Janssens HM, de Jongh FH, et al. What the pulmonary specialist should know about the new inhalation therapies. Eur Respir J 2011; 37: 1308-1331.
181. Leone FT, Fish JE, Szefler SJ, et al. Systematic review of the evidence regarding potential complications of inhaled corticosteroid use in asthma: collaboration of American College of Chest Physicians, American Academy of Allergy, Asthma, and Immunology, and American College of Allergy, Asthma, and Immunology. Chest 2003; 124: 2329-2340.
182. Pedersen S. Do the benefits of daily inhaled steroid treatment of mild asthma outweigh the risks? Arch Dis Child 2008; 93: 644-645.
183. Pedersen S. Do inhaled corticosteroids inhibit growth in children? Am J Respir Crit Care Med 2001; 164: 521-535.
184. Agertoft L, Pedersen S. Effect of long-term treatment with inhaled budesonide on adult height in children with asthma. N Engl J Med 2000; 343: 1064-1069.
185. Kelly HW, Sternberg AL, Lescher R, et al. Effect of inhaled glucocorticoids in childhood on adult height. N Engl J Med 2012; 367: 904-912.
186. Todd GR, Acerini CL, Ross-Russell R, et al. Survey of adrenal crisis associated with inhaled corticosteroids in the United Kingdom. Arch Dis Child 2002; 87: 457-461.
187. Zollner EW, Lombard CJ, Galal U, et al. Hypothalamic-pituitary-adrenal axis suppression in asthmatic school children. Pediatrics 2012; 130: e1512-e1519.
188. Carlsen KH. Inhaled steroids and local side-effects. Allergy 2001; 56: 925-927.
189. de Groot EP, Duiverman EJ, Brand PL. Comorbidities of asthma during childhood: possibly important, yet poorly studied. Eur Respir J 2010; 36: 671-678.
190. Chawes BL, Bonnelykke K, Kreiner-Moller E, et al. Children with allergic and nonallergic rhinitis have a similar risk of asthma. J Allergy Clin Immunol 2010; 126: 567-573.
191. Kang HY, Park CS, Bang HR, et al. Effect of allergic rhinitis on the use and cost of health services by children with asthma. Yonsei Med J 2008; 49: 521-529.
192. Kiotseridis H, Cilio CM, Bjermer L, et al. Quality of life in children and adolescents with respiratory allergy, assessed with a generic and disease-specific instrument. Clin Respir J 2013; 7: 168-175.
193. Bergstrom SE, Boman G, Eriksson L, et al. Asthma mortality among Swedish children and young adults, a 10-year study. Respir Med 2008; 102: 1335-1341.
194. Chafen JJ, Newberry SJ, Riedl MA, et al. Diagnosing and managing common food allergies: a systematic review. JAMA 2010; 303: 1848-1856.
195. Nicolaou N, Poorafshar M, Murray C, et al. Allergy or tolerance in children sensitized to peanut: prevalence and differentiation using component-resolved diagnostics. J Allergy Clin Immunol 2010; 125: 191-197.
196. de Jong AB, Dikkeschei LD, Brand PL. Sensitization patterns to food and inhalant allergens in childhood: a comparison of non-sensitized, monosensitized, and polysensitized children. Pediatr Allergy Immunol 2011; 22: 166-171.
197. Muraro A, Roberts G, Worm M, et al. Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology. Allergy 2014; 69: 1026-1045.
198. Blondeau K, Mertens V, Dupont L, et al. The relationship between gastroesophageal reflux and cough in children with chronic unexplained cough using combined impedance-pH-manometry recordings. Pediatr Pulmonol 2011; 46: 286-294.
199. Tolia V, Vandenplas Y. Systematic review: the extra-oesophageal symptoms of gastro-oesophageal reflux disease in children. Aliment Pharmacol Ther 2009; 29: 258-272.
200. Stordal K, Johannesdottir GB, Bentsen BS, et al. Acid suppression does not change respiratory symptoms in children with asthma and gastro-oesophageal reflux disease. Arch Dis Child 2005; 90: 956-960.
201. Writing Committee for the American Lung Association Asthma Clinical Research Centers, Holbrook JT, Wise RA, Gold BD, et al. Lansoprazole for children with poorly controlled asthma: a randomized controlled trial. JAMA 2012; 307: 373-381.
202. Cibella F, Cuttitta G, La Grutta S, et al. A cross-sectional study assessing the relationship between BMI, asthma, atopy, and eNO among schoolchildren. Ann Allergy Asthma Immunol 2011; 107: 330-336.
203. Corbo GM, Forastiere F, De Sario M, et al. Wheeze and asthma in children - associations with body mass index, sports, television viewing, and diet. Epidemiology 2008; 19: 747-755.
204. Forno E, Lescher R, Strunk R, et al. Decreased response to inhaled steroids in overweight and obese asthmatic children. J Allergy Clin Immunol 2011; 127: 741-749.
205. O'Byrne PM, Pedersen S, Schatz M, et al. The poorly explored impact of uncontrolled asthma. Chest 2013; 143: 511-523.
206. Schachter LM, Peat JK, Salome CM. Asthma and atopy in overweight children. Thorax 2003; 58: 1031-1035.
207. Collins RA, Parsons F, Deverell M, et al. Risk factors for bronchial hyperresponsiveness in teenagers differ with sex and atopic status. J Allergy Clin Immunol 2011; 128: 301-307.
208. Kabir Z, Manning PJ, Holohan J, et al. Second-hand smoke exposure in cars and respiratory health effects in children. Eur Respir J 2009; 34: 629-633.
209. Vargas PA, Brenner B, Clark S, et al. Exposure to environmental tobacco smoke among children presenting to the emergency department with acute asthma: a multicenter study. Pediatr Pulmonol 2007; 42: 646-655.
210. Cook DG, Strachan DP. Summary of effects of parental smoking on the respiratory health of children and implications for research. Thorax 1999; 54: 357-365.
211. Chang MY, Hogan AD, Rakes GP, et al. Salivary cotinine levels in children presenting with wheezing to an emergency department. Pediatr Pulmonol 2000; 29: 257-263.
212. Gerald LB, Gerald JK, Gibson L, et al. Changes in environmental tobacco smoke exposure and asthma morbidity among urban school children. Chest 2009; 135: 911-916.
213. Wilson SR, Farber HJ, Knowles SB, et al. A randomized trial of parental behavioral counseling and cotinine feedback for lowering environmental tobacco smoke exposure in children with asthma: results of the LET'S Manage Asthma Trial. Chest 2011; 139: 581-590.
214. Priest N, Roseby R, Waters E, et al. Family and carer smoking control programmes for reducing children's exposure to environmental tobacco smoke. Cochrane Database Syst Rev 2008; 8: CD001746.
215. Plopper CG, Fanucchi MV. Do urban environmental pollutants exacerbate childhood lung diseases? Environ Health Perspect 2000; 108: A252-A253.
216. Pinkerton KE, Joad JP. The mammalian respiratory system and critical windows of exposure for children's health. Environ Health Perspect 2000; 108: Suppl. 3, 457-462.
217. Kim JJ, American Academy of Pediatrics Committee on Environmental Health. Ambient air pollution: health hazards to children. Pediatrics 2004; 114: 1699-1707.
218. Dietert RR, Etzel RA, Chen D, et al. Workshop to identify critical windows of exposure for children' s health: immune and respiratory systems work group summary. Environ Health Perspect 2000; 108: Suppl. 3, 483-490.
219. European Centre for Environment and Health. Effects of air pollution on children's health and development. A review of evidence. Special Programme on Health and Development. Denmark, European Centre for Environment and Health, 2005.
220. Gauderman WJ, Avol E, Gilliland F, et al. The effect of air pollution on lung development from 10 to 18 years of age. N Engl J Med 2004; 351: 1057-1067.
221. Morgan WJ, Crain EF, Gruchalla RS, et al. Results of a home-based environmental intervention among urban children with asthma. N Engl J Med 2004; 351: 1068-1080.
222. Gøtzsche PC, Johansen HK. House dust mite control measures for asthma. Cochrane Database Syst Rev 2008; 2: CD001187.
223. Platts-Mills TA. Allergen avoidance in the treatment of asthma: problems with the meta-analyses. J Allergy Clin Immunol 2008; 122: 694-696.